Comparative killing kinetics of methicillin-resistant staphylococcus aureus by bacitracin or mupirocin

Infection Control and Hospital Epidemiology

Volumn 17, Issue 3, 1996, Pages 178-180

  Chapnick, Edward K ^b   Gradon, Jeremy D ^b   Kreiswirth, Barry ^b   Lutwick, Larry I ^b   Schaffer, Benjamin C ^b   Schiano, Thomas D ^b   Levi, Michael H ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACITRACIN; PSEUDOMONIC ACID; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; IN VITRO STUDY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; TIME; UNITED STATES;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACITRACIN; METHICILLIN RESISTANCE; MUPIROCIN; NEW YORK; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 0030097078     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30142381     Document Type: Review

References (10)

1. Brumfit W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989;320:1188-1196.
2. Bryan CS, Wilson RS, Meade P, Sill LG. Topical antibiotic ointments for staphylococcal nasal carriers: survey of current practices and comparison of bacitracin and vancomycin ointments. Infect Control 1980;1:153-156.
3. Bradley SF, Ramsey MA, Morton TM, Kauffman CA. Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol 1995;16:354-358.
4. Frank U, Lenz W, Damrath E, Kappstein I, Daschner FD. Nasal carriage of Staphylococcus aureus treated with topical mupirocin (pseudomonic acid) in a children's hospital. J Hosp Infect 1989;13:117-120.
5. Kreiswirth BN, Kornbluth J, Arbeit RD, et al. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 1992;259:227-230.
6. Muder RR, Brennen C, Wagener MM, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991;114:107-112.
7. McAnally TP, Lewis MR, Brown DR. The effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother 1984;25:422-426.
8. Casewell MW, Hill RLR. In-vitro activity of mupirocin (pseudomonic acid) against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 1985;15:523-531.
9. Kauffman CA, Terpenning MS, He X, Zarins LT, Ramsay MA, Jorgenson KA. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long term care facility with the use of mupirocin ointment. Am J Med 1993;94:371-378.
10. Reagan DR, Doebbeling DN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991;114:101-106.